Dynamics of pancreatic insulin release in young Zucker rats

a heterozygote effect.

E. R. Blonz, J. S. Stern, D. L. Curry

Research output: Contribution to journalArticle

Abstract

Total pancreatic insulin, dynamic insulin response to glucose (325 mg/dl), or tolbutamide (40 mg/dl) using the isolated perfused pancreas preparation and body composition were determined for 2- and 4-wk-old homozygous lean Fa/Fa, heterozygous lean Fa/fa, unknown lean Fa/??, and homozygous obese fa/fa female Zucker rats. At 2-wk, obese rats (body fat greater than 16%) released significantly more insulin than homozygous lean rats during first (min 10-16) and second phases (min 17-70) (61 vs. 30 ng and 637 vs. 255 ng, respectively). Plasma insulinemia was 177 microU/ml in obese, compared with 51 microU/ml in homozygous lean rats. The dynamic response of unknown lean followed the pattern of either the homozygous lean or the obese rats. There was no significant difference in total pancreatic insulin among any of the groups at 2 wk of age (Fa/Fa, 1.72; Fa/??, 2.01; and Fa/Fa, 1.80 micrograms). At 4 wk, the dynamic response by obese (2.98 micrograms) was similar to that of heterozygous (3.31 micrograms), both being significantly greater than the homozygous lean (1.14 micrograms) or unknown lean rats (1.77 microgram). Total pancreatic insulin in 4-wk obese (19.8 micrograms) was greater than homozygous lean rats (14.5 micrograms). Tolbutamide-stimulated insulin release was significantly greater in 4-wk obese than homozygous lean rats. Exposure to tolbutamide reduced by 60% the second-phase insulin release in both obese and homozygous lean rats during a subsequent 40-min glucose (325 mg/dl) perfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Original languageEnglish (US)
JournalThe American journal of physiology
Volume248
Issue number2 Pt 1
StatePublished - Feb 1985
Externally publishedYes

Fingerprint

Zucker Rats
Heterozygote
Insulin
Tolbutamide
Glucose
Body Composition
Adipose Tissue
Pancreas
Perfusion

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dynamics of pancreatic insulin release in young Zucker rats : a heterozygote effect. / Blonz, E. R.; Stern, J. S.; Curry, D. L.

In: The American journal of physiology, Vol. 248, No. 2 Pt 1, 02.1985.

Research output: Contribution to journalArticle

Blonz, E. R. ; Stern, J. S. ; Curry, D. L. / Dynamics of pancreatic insulin release in young Zucker rats : a heterozygote effect. In: The American journal of physiology. 1985 ; Vol. 248, No. 2 Pt 1.
@article{3232e930898e4d6d956a3e917aa54784,
title = "Dynamics of pancreatic insulin release in young Zucker rats: a heterozygote effect.",
abstract = "Total pancreatic insulin, dynamic insulin response to glucose (325 mg/dl), or tolbutamide (40 mg/dl) using the isolated perfused pancreas preparation and body composition were determined for 2- and 4-wk-old homozygous lean Fa/Fa, heterozygous lean Fa/fa, unknown lean Fa/??, and homozygous obese fa/fa female Zucker rats. At 2-wk, obese rats (body fat greater than 16{\%}) released significantly more insulin than homozygous lean rats during first (min 10-16) and second phases (min 17-70) (61 vs. 30 ng and 637 vs. 255 ng, respectively). Plasma insulinemia was 177 microU/ml in obese, compared with 51 microU/ml in homozygous lean rats. The dynamic response of unknown lean followed the pattern of either the homozygous lean or the obese rats. There was no significant difference in total pancreatic insulin among any of the groups at 2 wk of age (Fa/Fa, 1.72; Fa/??, 2.01; and Fa/Fa, 1.80 micrograms). At 4 wk, the dynamic response by obese (2.98 micrograms) was similar to that of heterozygous (3.31 micrograms), both being significantly greater than the homozygous lean (1.14 micrograms) or unknown lean rats (1.77 microgram). Total pancreatic insulin in 4-wk obese (19.8 micrograms) was greater than homozygous lean rats (14.5 micrograms). Tolbutamide-stimulated insulin release was significantly greater in 4-wk obese than homozygous lean rats. Exposure to tolbutamide reduced by 60{\%} the second-phase insulin release in both obese and homozygous lean rats during a subsequent 40-min glucose (325 mg/dl) perfusion.(ABSTRACT TRUNCATED AT 250 WORDS)",
author = "Blonz, {E. R.} and Stern, {J. S.} and Curry, {D. L.}",
year = "1985",
month = "2",
language = "English (US)",
volume = "248",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "2 Pt 1",

}

TY - JOUR

T1 - Dynamics of pancreatic insulin release in young Zucker rats

T2 - a heterozygote effect.

AU - Blonz, E. R.

AU - Stern, J. S.

AU - Curry, D. L.

PY - 1985/2

Y1 - 1985/2

N2 - Total pancreatic insulin, dynamic insulin response to glucose (325 mg/dl), or tolbutamide (40 mg/dl) using the isolated perfused pancreas preparation and body composition were determined for 2- and 4-wk-old homozygous lean Fa/Fa, heterozygous lean Fa/fa, unknown lean Fa/??, and homozygous obese fa/fa female Zucker rats. At 2-wk, obese rats (body fat greater than 16%) released significantly more insulin than homozygous lean rats during first (min 10-16) and second phases (min 17-70) (61 vs. 30 ng and 637 vs. 255 ng, respectively). Plasma insulinemia was 177 microU/ml in obese, compared with 51 microU/ml in homozygous lean rats. The dynamic response of unknown lean followed the pattern of either the homozygous lean or the obese rats. There was no significant difference in total pancreatic insulin among any of the groups at 2 wk of age (Fa/Fa, 1.72; Fa/??, 2.01; and Fa/Fa, 1.80 micrograms). At 4 wk, the dynamic response by obese (2.98 micrograms) was similar to that of heterozygous (3.31 micrograms), both being significantly greater than the homozygous lean (1.14 micrograms) or unknown lean rats (1.77 microgram). Total pancreatic insulin in 4-wk obese (19.8 micrograms) was greater than homozygous lean rats (14.5 micrograms). Tolbutamide-stimulated insulin release was significantly greater in 4-wk obese than homozygous lean rats. Exposure to tolbutamide reduced by 60% the second-phase insulin release in both obese and homozygous lean rats during a subsequent 40-min glucose (325 mg/dl) perfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

AB - Total pancreatic insulin, dynamic insulin response to glucose (325 mg/dl), or tolbutamide (40 mg/dl) using the isolated perfused pancreas preparation and body composition were determined for 2- and 4-wk-old homozygous lean Fa/Fa, heterozygous lean Fa/fa, unknown lean Fa/??, and homozygous obese fa/fa female Zucker rats. At 2-wk, obese rats (body fat greater than 16%) released significantly more insulin than homozygous lean rats during first (min 10-16) and second phases (min 17-70) (61 vs. 30 ng and 637 vs. 255 ng, respectively). Plasma insulinemia was 177 microU/ml in obese, compared with 51 microU/ml in homozygous lean rats. The dynamic response of unknown lean followed the pattern of either the homozygous lean or the obese rats. There was no significant difference in total pancreatic insulin among any of the groups at 2 wk of age (Fa/Fa, 1.72; Fa/??, 2.01; and Fa/Fa, 1.80 micrograms). At 4 wk, the dynamic response by obese (2.98 micrograms) was similar to that of heterozygous (3.31 micrograms), both being significantly greater than the homozygous lean (1.14 micrograms) or unknown lean rats (1.77 microgram). Total pancreatic insulin in 4-wk obese (19.8 micrograms) was greater than homozygous lean rats (14.5 micrograms). Tolbutamide-stimulated insulin release was significantly greater in 4-wk obese than homozygous lean rats. Exposure to tolbutamide reduced by 60% the second-phase insulin release in both obese and homozygous lean rats during a subsequent 40-min glucose (325 mg/dl) perfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

UR - http://www.scopus.com/inward/record.url?scp=0022017118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022017118&partnerID=8YFLogxK

M3 - Article

VL - 248

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 2 Pt 1

ER -